Mesa Laboratories, Inc.
NASDAQ:MLABHardware, Equipment & Parts
-$0.15 today
- Market cap
- $774.56M
- Beta
- 0.93
- P/E (TTM)
- 78.3
- EPS (TTM)
- $1.21
- Dividend yield
- 0.68%
Volume 0.07M
Average 0.16M
MLAB Depreciation & Amortization
Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.
Mesa Laboratories, Inc.NASDAQ: MLAB
Depreciation & Amortization · Q4 FY2026 · quarter ended Mar 2026
Depreciation & amortization declines year over year
Q4 FY2026 depreciation & amortization of $5.75M fell 23.3% year over year, behind the -5.1% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 0.6% from the prior quarter. Over 3 fiscal years it compounded at -11.1% a year.
Context
- Depreciation & amortization amounted to 9.3% of revenue in FY2026, down 0.8 pp from a year earlier.
- Depreciation & amortization increased in 0 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -23.3% toward the trailing-twelve-month pace of -5.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the income statement
- Latest · FY2026
- 23.27M USD
- Year-over-year change
- -5.1%
- 4-year CAGR
- -1.8%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 23.27M | -5.1% |
| FY2025 | 2025-03-31 | 24.53M | -22.3% |
| FY2024 | 2024-03-31 | 31.57M | -4.7% |
| FY2023 | 2023-03-31 | 33.13M | +32.2% |
| FY2022 | 2022-03-31 | 25.07M | — |
Depreciation & Amortization vs competitors
How MLAB compares with its peers on the latest reported figures
- MLAB's LTM Mar 2026 depreciation & amortization of $23.27M is the 9th highest of the 11 companies compared; the peer median is $112.17M.
- Its year-over-year change of -5.1% is the 4th highest of 11, against a peer median of -13.6%.
- Depreciation & amortization amounts to 9.3% of revenue for MLAB, versus a peer median of 7.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $2.28B | -18.3% | -6.3% | 4.8% | |
| LTM Jul 2026 | $412.24M | -0.2% | -1.7% | 14.2% | |
| LTM Jul 2026 | $271M | -5.2% | -3.1% | 3.7% | |
| LTM Jun 2026 | $202.13M | +7.0% | -2.4% | 9.6% | |
| LTM Jun 2026 | $127.6M | -23.5% | +6.4% | 4.9% | |
| LTM Sep 2026 | $96.75M | -8.8% | -3.2% | 7.9% | |
| LTM Jun 2026 | $56.96M | -3.2% | +16.6% | 27.3% | |
| LTM Sep 2026 | $33.67M | -20.4% | +9.9% | 5.4% | |
| LTM Mar 2026 | $23.27M | -5.1% | -11.1% | 9.3% | |
| LTM Mar 2026 | $17.69M | -95.7% | +207.8% | 11.1% | |
| LTM Mar 2026 | $6.29M | -60.3% | -22.5% | 7.3% | |
| Peer median (excluding MLAB) | $112.17M | -13.6% | -2.1% | 7.6% | |
Competitors are the stored peer set for MLAB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 184.34M | 219.08M | 216.19M | 240.98M | 249.13M |
| Cost of Revenue | 75.25M | 85.39M | 82.94M | 90.11M | 90.86M |
| Gross Profit | 109.09M | 133.69M | 133.25M | 150.87M | 158.27M |
| Gross Margin | 59.2% | 61.0% | 61.6% | 62.6% | 63.5% |
| Research & Development | 15.77M | 20.49M | 19.3M | 19.52M | 20.31M |
| Selling, General & Admin | 88.62M | 109.88M | 111.49M | 115.02M | 119.45M |
| Operating Expenses | 104.39M | 130.37M | 405.33M | 134.53M | 139.76M |
| Depreciation & Amortization | 25.07M | 33.13M | 31.57M | 24.53M | 23.27M |
| EBITDA | 32.53M | 37.52M | (238.38M) | 42.35M | 35.29M |
| EBITDA Margin | 17.6% | 17.1% | -110.3% | 17.6% | 14.2% |
| Operating Income | 4.7M | 3.32M | (272.08M) | 16.34M | 18.51M |
| Operating Margin | 2.6% | 1.5% | -125.9% | 6.8% | 7.4% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 3.89M | 4.77M | 5.7M | 11.86M | 10.69M |
| Other Income / Expenses | (1.13M) | (3.71M) | (3.57M) | (10.38M) | (6.5M) |
| Income Before Tax | 3.57M | (389K) | (275.65M) | 5.96M | 12.01M |
| Pre-Tax Margin | 1.9% | -0.2% | -127.5% | 2.5% | 4.8% |
| Income Tax Expense | 1.7M | (1.32M) | (21.4M) | 7.94M | 5.3M |
| Net Income | 1.87M | 930K | (254.25M) | (1.97M) | 6.71M |
| Net Margin | 1.0% | 0.4% | -117.6% | -0.8% | 2.7% |
| EPS (Basic) | 0.36 | 0.17 | (47.20) | (0.36) | 1.22 |
| EPS (Diluted) | 0.35 | 0.17 | (47.20) | (0.36) | 1.21 |
| Weighted Avg Shares | 5.21M | 5.32M | 5.39M | 5.43M | 5.51M |
| Weighted Avg Shares (Diluted) | 5.34M | 5.36M | 5.39M | 5.43M | 5.57M |
Mesa Laboratories, Inc.
NASDAQ:MLAB
Intrinsic Alpha fair value
Locked
Current Price
$137.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.